Anivive (8/10/2021)

CB Partner Webinar {{webinarsregistrationpage::webinar_title}} {{webinarsregistrationpage::race_approved}} true 1 Credit Hour {{webinarsregistrationpage::hero_image}} {{webinarsregistrationpage::hero_image_self_hosted}} {{webinarsregistrationpage::hero_image_desktop_background_position}} {{webinarsregistrationpage::hero_image_mobile_background_position}} {{webinarsregistrationpage::hero_image_custom_padding}} {{webinarsregistrationpage::hero_image_custom_padding_mobile}} Anivive {{webinarsregistrationpage::supported_by}} {{webinarsregistrationpage::multiple_speakers}}

Thanks to improvements in diagnostics and an increase in treatment options, primary care teams are playing a bigger and bigger role in the care of canine lymphoma patients. In this webinar, medical oncologist Dr. Avenelle Turner will review recently developed guidelines for primary care treatment protocols designed to optimize outcomes for canine lymphoma patients. Discussion will also focus on how the SINE class of drugs works to kill cancer cells and where they can be incorporated into your treatment plans. Plus, find out what kind of patient may benefit from LAVERDIA™-CA1 (verdinexor), a new oral medication pet owners can use to treat lymphoma at home.

{{webinarsregistrationpage::inside_the_webinar_2}} {{webinarsregistrationpage::inside_the_webinar_3}} Recommended diagnostics that can inform tailored treatment protocols An oncologist’s advice for talking to clients about a cancer diagnosis and treatment options When and how to start treating lymphoma patients in your practice What to do for patients waiting to see a specialist How the new SINE class of drugs work {{webinarsregistrationpage::what_youll_learn_bullet_6}} Company Description

Anivive Lifesciences is a biotechnology company focused on developing first-in-class therapeutics for veterinary patients. Anivive’s commitment to using software to more effectively and efficiently develop new drugs helped bring LAVERDIA-CA1 to market and expand access to cancer care.

In adherence with RACE guidelines, CE certificates can only be distributed to individual registrants under the name used upon registration. Group viewers will not be eligible to receive multiple CE certificates.